AMPIO PHARMACEUTICALS INC's ticker is AMPE and the CUSIP is 03209T109. A total of 92 filers reported holding AMPIO PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is 0.08 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $17,000 | -29.2% | 36,533 | -14.2% | 0.00% | – |
| Q4 2021 | $24,000 | -41.5% | 42,565 | +70.5% | 0.00% | – |
| Q3 2021 | $41,000 | -50.0% | 24,967 | -49.4% | 0.00% | – |
| Q2 2021 | $82,000 | +1950.0% | 49,347 | +375.8% | 0.00% | – |
| Q2 2019 | $4,000 | -33.3% | 10,371 | -2.6% | 0.00% | – |
| Q1 2019 | $6,000 | +50.0% | 10,645 | +3.2% | 0.00% | – |
| Q4 2018 | $4,000 | -33.3% | 10,313 | -13.9% | 0.00% | – |
| Q3 2018 | $6,000 | -73.9% | 11,976 | +14.6% | 0.00% | – |
| Q2 2018 | $23,000 | -59.6% | 10,447 | -35.7% | 0.00% | -100.0% |
| Q3 2014 | $57,000 | -65.7% | 16,255 | -18.5% | 0.00% | -50.0% |
| Q2 2014 | $166,000 | -17.0% | 19,935 | -36.7% | 0.00% | -33.3% |
| Q1 2014 | $200,000 | +52.7% | 31,498 | +80.3% | 0.00% | 0.0% |
| Q3 2013 | $131,000 | +35.1% | 17,465 | +4.4% | 0.00% | +50.0% |
| Q2 2013 | $97,000 | – | 16,725 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 5,265,265 | $2,042,000 | 2.57% |
| Cypress Capital Management LLC (WY) | 288,225 | $112,000 | 0.13% |
| Harvest Investment Services, LLC | 109,443 | $45,000 | 0.03% |
| Noven Financial Group, Inc. | 123,772 | $48,000 | 0.02% |
| COURIER CAPITAL LLC | 379,973 | $147,000 | 0.02% |
| Valeo Financial Advisors, LLC | 330,000 | $128,000 | 0.02% |
| STEEL GROVE CAPITAL ADVISORS, LLC | 55,500 | $22,000 | 0.01% |
| Transform Wealth, LLC | 205,481 | $80,000 | 0.01% |
| Strategic Financial Services, Inc. | 140,000 | $54,000 | 0.01% |
| Traynor Capital Management, Inc. | 48,562 | $20,000 | 0.01% |